# Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)

> **NCT07439133** · PHASE3 · RECRUITING · sponsor: **Sinotau Pharmaceutical Group** · enrollment: 395 (estimated)

## Conditions studied

- Coronary Artery Disease(CAD)

## Interventions

- **DRUG:** XTR004

## Key facts

- **NCT ID:** NCT07439133
- **Lead sponsor:** Sinotau Pharmaceutical Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-14
- **Primary completion:** 2027-06
- **Final completion:** 2027-10
- **Target enrollment:** 395 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07439133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07439133, "Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07439133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*